Read more at http://www.ripplesadvisory.com/nifty-future-.php
Results today: SBI, Bank of Baroda, Tata Power, M&M, Hindustan Zinc
Taro Pharma Q3 ( Sun Pharma subsidiary)
-Net sales down 14.7 percent at USD 220.4 million (YoY)
-Net income down 26 percent at USD 139.8 million versus USD 189 million (YoY)
-Operating margin at 58.5 percent versus 67.1 percent (YoY)
BPCL Q3
-Net profit up 74.1 percent at Rs 2,271.9 crore versus Rs 1,305.2 crore (QoQ)
-Total income up 16.7 percent at Rs 64,095.7 crore versus Rs 54,913 crore (QoQ)
-EBITDA at Rs 3,316.5 crore versus Rs 1,381.4 crore (QoQ)
-EBITDA margin at 5.2 percent versus 2.5 percent (QoQ)
Aurobindo Pharma Q3
-Consolidated Net Profit Up 6.3 percent At Rs 578.6 Crore Versus Rs 544.3 Crore (YoY)
-Consolidated Total Income Up 11.4 percent At Rs 3,906.2 Crore Versus Rs 3,505.6 Crore (YoY)
-Consolidated EBITDA Up 9.4 percent At Rs 894.8 Crore Versus Rs 817.8 Crore (YoY)
Power Grid Q3
-Net Profit Up 20.2 percent At Rs 1,930 Crore Versus Rs 1,606 Crore (YoY)
-Total Income Up 23.5 percent At Rs 6,629.8 Crore Versus Rs 5369.5 Crore (YoY)
-EBITDA Up 24.4 percent At Rs 5.958.9 Crore Versus Rs 4788.2 Crore (YoY)
-EBITDA Margin At 89.9 percent Versus 89.2 percent (YoY)

No comments:
Post a Comment